Photobiomodulation, once called low-level laser therapy, uses red or near-infrared light at doses that do not heat the tissue to modulate cellular activity and promote healing. In dentistry the therapy has moved from a curiosity to a documented adjunct for pain, inflammation, and wound recovery, ...

Photobiomodulation, once called low-level laser therapy, uses red or near-infrared light at doses that do not heat the tissue to modulate cellular activity and promote healing. In dentistry the therapy has moved from a curiosity to a documented adjunct for pain, inflammation, and wound recovery, backed by a growing number of clinical trials. This article explains how the therapy works, the evidence for its main uses, and the practical parameters that separate a useful dose from an ineffective one.
Light in the red and near-infrared part of the spectrum is absorbed by mitochondrial cytochrome c oxidase, which in turn increases cellular respiration and the production of adenosine triphosphate. In 2009 Huang and colleagues summarized this mechanism in a widely cited review and described the so-called biphasic dose response, in which low doses stimulate and excessive doses inhibit. The same review emphasized that the window between benefit and harm is real, making the delivered dose the central variable in every treatment.
During acute injury the absorbed light reduces oxidative stress and inflammation, while in the healing phase it stimulates the fibroblasts, endothelial cells, and osteoblasts that rebuild the tissue. This explains why the same device is used both for acute pain and for chronic soft-tissue problems. The practical consequence is that the clinician must adapt wavelength, power, and exposure to the condition being treated rather than relying on a single default setting.
| Parameter | Typical dental values | Clinical effect |
|---|---|---|
| Wavelength | 600–660 nm and 800–900 nm | Deeper penetration in the near-infrared |
| Power | 50–500 mW | Determines dose per unit time |
| Energy density | 3–8 J/cm² commonly cited | Biphasic: too high reverses benefit |
| Application time | 1–3 minutes per site | Avoids overheating of the tissue |
Randomized trials report that photobiomodulation reduces pain after third molar surgery and after periodontal or orthodontic treatment, with several studies documenting lower visual analogue scale scores in the laser group compared with control. A 2019 meta-analysis of postoperative pain after third molar extraction favored laser therapy for pain reduction on the first and third postoperative days. The effect is most convincing when the treatment is delivered within the first hours after the procedure and repeated over the following days. A prospective study published in 2021 in Lasers in Medical Science reported reduced pain and an earlier return to normal function after laser-assisted extraction healing, mirroring the earlier meta-analytic findings.
For oral mucositis induced by cancer treatment, systematic reviews support photobiomodulation as an effective way to reduce the severity and duration of the lesions, and clinical guidelines now list it among the recommended interventions. The same mechanism assists the healing of recurrent aphthous ulcers, with placebo-controlled studies showing faster resolution and less pain in the treated group. These soft-tissue indications are the best documented, because the light is applied close to the surface where its dose is easiest to control.
| Indication | Typical protocol | Reported benefit |
|---|---|---|
| Postoperative pain | 1–3 J/cm², 48–72 hours | Lower pain scores, fewer analgesics |
| Oral mucositis | Multiple sessions, low dose | Reduced severity and duration |
| Aphthous ulcers | 0.5–2 J/cm² per lesion | Faster healing, earlier pain relief |
| Nerve and TMJ pain | Higher near-infrared doses | Mixed evidence, discuss with patient |
The evidence for temporomandibular pain is promising but mixed, with some randomized trials reporting reduced muscle tenderness and improved mouth opening and others showing no advantage over a placebo. For neurosensory disturbance after implant placement or third molar surgery, reports describe accelerated recovery of sensation with near-infrared doses, although controlled data remain limited. These indications illustrate the honest state of the field: strong for mucositis and postoperative pain, moderate and case-dependent for joints and nerves.
The operator should start from the biphasic response and choose an energy density in the stimulating range, commonly 3 to 8 J/cm² for soft tissue, and apply it once daily or every other day depending on the condition. A single treatment rarely suffices, and repeated sessions separated by a day typically produce the best results. The probe must make light contact with the mucosa or be held a few millimeters away, and the output of the device should be verified against its specification. Clinicians new to the technology will find practical dose tables and case examples in the educational libraries that platforms such as BrushO compile for continuing dental education.
Photobiomodulation is most effective when it is part of a broader protocol rather than a standalone miracle. For a patient recovering from an extraction or an implant, pairing the laser with the standard anti-inflammatory advice and a review appointment reinforces the biological advantage the light provides. Devices designed for the dental chair make this simple, and with the correct parameters the therapy adds minutes to a visit while giving the patient a measurable improvement in comfort. Recording the dose, the sites treated, and the number of sessions in the progress notes makes the outcome easy to audit at the review visit.
- Red and near-infrared light stimulates mitochondria and cellular repair.
- The dose response is biphasic: correct doses help, excess doses harm.
- Best evidence supports mucositis, postoperative pain, and ulcer healing.
- 3 to 8 J/cm² delivered over repeated sessions is a common starting point.
- TMJ and nerve indications show mixed but encouraging evidence.
- The therapy is an adjunct, not a substitute, for sound clinical care.
Photobiomodulation has grown from a peripheral claim into one of the better-documented physical therapies available to the dental team, with robust support for mucositis and postoperative pain and a reasonable case for ulcers and musculoskeletal discomfort. Its success depends almost entirely on the discipline of the operator, who must respect wavelength, dose, and schedule rather than reaching for a single cure-all setting. Used in this careful way, the laser gives both the clinician and the patient a simple, non-invasive tool that genuinely accelerates the healing the mouth already intends.
Sep 9
Sep 9

Squamous cell carcinoma is not a single, uniform disease, and two of its oral variants illustrate the extremes of its behavior. Verrucous carcinoma is a slow-growing, exophytic tumor that almost never metastasizes, while spindle cell carcinoma is an aggressive, sarcomatoid malignancy that can be ...

Most people expect a toothache to be the first sign of pulp disease, but some forms of pulpitis are surprisingly silent. A pulp polyp is the visible result of chronic hyperplastic pulpitis, a condition in which the dental pulp grows out of a large carious opening as a fleshy mass. Recognizing thi...

Dry mouth is not merely uncomfortable; it is a medical condition with real consequences for teeth, speech, swallowing and quality of life. When the salivary glands cannot produce enough saliva, medications called sialogogues can restore some of the missing fluid. Pilocarpine and cevimeline are th...

A blister in the mouth can be the first warning of a systemic autoimmune disease, and two disorders deserve particular attention in the dental chair: pemphigus vulgaris and mucous membrane pemphigoid. Both produce chronic oral ulceration, yet their immunologic targets, clinical behavior and long-...

When infection drains from a tooth, the body often creates a visible escape route, and the dentist must interpret these fistulous openings correctly. A parulis is the common gum boil that signals chronic periapical infection, while an oroantral fistula is a communication between the mouth and the...

Among the fibro-osseous lesions of the jaws, the ossifying fibroma holds a unique position because it is a true neoplasm, unlike the reactive cemento-osseous dysplasia discussed in an earlier article. It grows continuously, expands bone and requires surgical removal, and its cemental variant adds...

Not all keratocystic lesions of the jaw behave alike, and one of the most important distinctions in oral pathology separates the orthokeratinized odontogenic cyst from its better-known relative, the odontogenic keratocyst. Although the two lesions look similar under the microscope at first glance...

Periodontal disease is usually a slowly progressive infection, but a rare form called necrotizing ulcerative periodontitis destroys tissue with alarming speed. Unlike ordinary periodontitis, this condition produces necrotic, cratered papillae, deep pocketing and rapid bone loss, and it appears al...

Every parent has met the child who refuses to eat because of painful mouth sores, and most of these children have one of two viral illnesses: herpangina or hand, foot and mouth disease. Both are caused by enteroviruses, both produce fever and oral ulcers, and both are overwhelmingly common in you...

Cementoosseous dysplasia is one of the most common fibro-osseous lesions found on dental radiographs, yet it is also one of the most frequently misdiagnosed. The lesion replaces normal bone with cellular fibrous tissue and cementum-like material, and it appears in several forms that range from a ...